期刊文献+

儿童和青少年血浆自然发生的抗β淀粉样蛋白抗体的表达

Expression of naturally occurring plasma anti-β amyloid antibody in children and youngsters
下载PDF
导出
摘要 目的探讨自然发生的抗β淀粉样蛋白(Aβ)抗体在儿童和青少年血浆中的表达。方法将28名1-30岁的健康人群按10岁为1个年龄段分为3组,采用转基因动物模型、组织淀粉样斑块免疫活性(TAPIR)分析和免疫印迹法,分析各组血浆抗Aβ抗体的存在和免疫特性。结果抗Aβ抗体总发生率为27.8%,各年龄组TAPIR阳性率差异无统计学意义;其免疫特性与中老年健康对照者相似。结论抗Aβ抗体的出现可能早于脑实质Aβ和老年斑的形成。 Objective To explore the expression of naturally occurring plasma anti-βamyloid ( Aβ ) antibody in children and youngsters . Methods According to each 10 years, 28 healthy cases aged from 1 - 30 years old were diviedd to 3 groups. In the 3 groups, the plasma anti-Aβ antibody was detacted by immunostained with paraffin sections from Tg2576 mice brain to make a specific tissue amyloid plaque immunoreactivity (TAPIR) and immunoprecipitation analysis. Results The total occurrence rate of anti-Aβ antibody was 27.8%. There was no significant difference of TAPIR positive rate in each age group. They had the similar immunospecialties to middleaged and elderly healthy controls. Conclusion Plasma anti-Aβ antibody can be occured before amyloid deposits and senile plaques in brain.
出处 《临床神经病学杂志》 CAS 北大核心 2008年第3期161-163,共3页 Journal of Clinical Neurology
基金 国家自然科学基金(30700248) 人事部留学回国人员启动项目(2007年度) 广东省医学科研基金(A20055568 B2007148) 广州市留学归国人员启动基金(2006年度) 广州市医药卫生科技项目(2006年度)
关键词 抗β淀粉样蛋白抗体 青少年 ALZHEIMER病 anti-β amyloid antibody children and youngsters Alzheimer's disease
  • 相关文献

参考文献13

  • 1Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease : progress and problems on the road to therapeutics [ J ]. Science, 2002,297:353.
  • 2薛寿儒,杨小旺.血小板β-淀粉样肽前体蛋白免疫强度及异构体比率对Alzheimer病的诊断价值[J].临床神经病学杂志,2007,20(3):176-178. 被引量:5
  • 3Du Y, Dodel R, Hampel H, et al. Reduced levels of amyloid betapeptide antibody in Alzheimer's disease [ J ]. Neurology, 2001,57 : 801.
  • 4Weksler ME, Relkin N, Turkenich R, et al. Patients with Alzheimer's disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individuals[J]. Exp Gerontol,2002,37: 943.
  • 5Hyman BT, Smith C, Buldyrev I, et al. Autoantibodies to amyloidbeta and Alzheimer's disease[ J]. Ann Neurol,2001,49:808.
  • 6Nath A, Hall E, Tuzova M, et al. Autoantibodies to amyloid betapeptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development [ J ]. Neuromolecular Med ,2003,3:29.
  • 7Monsonego A, Zota V, Karni A, et al. Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease [ J ]. J Clin Invest,2003,112:415.
  • 8徐武华,东海林干夫,松原悦朗.阿尔茨海默病患者自身抗β淀粉样蛋白抗体的免疫特性和临床价值[J].中华老年医学杂志,2006,25(2):89-92. 被引量:5
  • 9Orgogozo JM, Gilman S, Dartigues JF, et al. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization [ J]. Neurology ,2003,61:46.
  • 10Hock C, Konietzko U, Streffer JR, et al. Antibodies against betaamyloid slow cognitive decline in Alzheimer's disease[ J ]. Neuron, 2003,38 : 547.

二级参考文献28

  • 1丁新生.重视Alzheimer病的诊治[J].临床神经病学杂志,2005,18(4):241-243. 被引量:17
  • 2Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 2002,297 : 353-356.
  • 3Schenk D, Barbour R, Dunn W, et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature, 1999, 400:173-177.
  • 4Nicoll JA, Wilkinson D, Holmes C, et al.Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptlde: a case report.Nat Med,2003, 9:448-452.
  • 5Hock C, Konietzko U, Streffer JR, et al. Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. Neuron, 2003, 38:547-554.
  • 6Du Y, Dodel R, Hampel H, et al. Reduced levels of amyloid beta-peptide antibody in Alzheimer disease.Neurology, 2001, 57 : 801-805.
  • 7Nath A, Hall E, Tuzova M, et al. Autoantibodies to amyloid beta-peptide ( Abeta ) are increased in AlzheimerPs disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development. Neuromolecular Med, 2003,3:29-39.
  • 8Hyman BT, Smith C, Buldyrev I, et al.Autoantibodies to amyloid-beta and Alzheimer' s disease. Ann Neurol, 2001, 49:808-810.
  • 9McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer' s disease., report of the NINCDS-ADRDA Work Group under the auspices of department of Health and Human Services Task Force on Alzheimer' s Disease. Neurology, 1984, 34:939-944.
  • 10Harigaya Y, Shoji M, Kawarabayashi, T, et al.Modified amyloid 13 protein ending at 42 or 40 with different solubility accumulates in the brain of Alzheimer's disease. Biochem Biophysic Res Comm,1995,211 : 1015-1022.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部